CDC data show declining STI rates, but condom supply chain disruptions due to the war in Iran may impact consumer pricing and future trends.

The IDSA released 2025 guidelines for treating mild to moderate COVID-19, emphasizing risk-based antiviral use to prevent ...

The FDA has approved Idvynso (doravirine/islatravir) for virologically suppressed adults with HIV-1 as a replacement for current treatment regimens.

A new Senate report found that drug companies involved in deals with President Trump have continued to raise prices on hundreds of medications.

A former surgeon general is weighing in on the president’s pick to lead the CDC, calling her highly qualified while warning of some potential challenges.

President Trump signed an executive order boosting federal research into substances and expanding their use in controlled treatment settings.

Ocrelizumab shows the highest association with urinary tract infections in patients with MS according to an FDA Adverse Event Reporting System analysis.

Health officials in some states are warning shoppers to avoid certain cantaloupes amid concerns they may carry Salmonella.

Gaps in vaccination and wound management contribute to preventable tetanus cases and deaths in the US, particularly among older adults.

Notes generated by artificial intelligence have lower-quality scores than those generated by humans across 5 standardized care cases.

PEPFAR treated about the same number of people in the last quarter of 2025 as it did a year earlier, but other key measures dropped sharply.

The FDA will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies.